Amtrak announced Thursday that it will extend current service levels between the Capital Region and New York City until late ...

This was the stock's third consecutive day of gains.

Regeneron is also embroiled in a securities fraud class action lawsuit stemming from a significant stock price drop on October 31, 2024. Shares plunged $84.59 that day, wiping out approximately $9 ...

On April 10, 2024, the U.S. Department of Justice announced it had filed a complaint against Regeneron under the False Claims Act. According to the DOJ, the Company failed to report millions of ...

Rensselaer Polytechnic Institute (RPI) and Rensselaer County are teaming up to launch a revolutionary business accelerator in ...

Regeneron has won a court ruling that will make it harder for U.S. authorities to win a lawsuit accusing it of paying illegal ...

2024 Regeneron Pharmaceuticals has settled allegations that it misused a patented protein to test its COVID-19 treatment REGEN-COV, according to filings in New York federal court. Regeneron ...

Regeneron Pharmaceuticals Inc. convinced the First Circuit to impose a higher causation standard in the government’s False Claims Act case alleging a drug kickback scheme, according to a Tuesday ...

RPI and Rensselaer County unveil "The Bridge," a new startup accelerator in downtown Troy, offering resources and support for ...

The 3.2 million-square-foot distribution center for Amazon would rise nearly five stories at the site, if the plans are ...

Regeneron Pharmaceuticals had a net margin of 33.61% and a return on equity of 16.88%. The company had revenue of $3.79 billion for the quarter, compared to analyst estimates of $3.76 billion.